A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines

Published:2017-08-11 Issue:38 Volume:56 Page:11539-11544
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Petruzzella Emanuele¹^ORCID,Braude Jeremy Phillip²^ORCID,Aldrich-Wright Janice R.³^ORCID,Gandin Valentina²^ORCID,Gibson Dan¹^ORCID

Affiliation:

1. Institute for Drug Research; School of Pharmacy; The Hebrew University; Jerusalem 91120 Israel

2. Dipartimento di Scienze del Farmaco; Università di Padova; Via Marzolo 5 35131 Padova Italy

3. School of Science and Health; Western Sydney University; Penrith South DC 1797 NSW Australia

Funder

Israel Science Foundation

Università degli Studi di Padova

Lady Davis Fellowship Trust, Hebrew University of Jerusalem

Publisher

Wiley

Subject

General Chemistry,Catalysis

Reference24 articles.

1. Chemotherapy and the war on cancer

2. Platinum(IV) antitumour compounds: their bioinorganic chemistry

3. What do we know about the reduction of Pt(IV) pro-drugs?

4. Satraplatin: an orally available platinum analog for the treatment of cancer

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A NIR iridium(III) complex-based luminescence probe for imaging mitochondria pyruvate dehydrogenase kinase 1 in triple-negative breast cancer cells;Sensors and Actuators B: Chemical;2024-11

2. Nucleus-targeting Oxaplatin(IV) prodrug Amphiphile for enhanced chemotherapy and immunotherapy;Journal of Controlled Release;2024-09

3. Cascade targeting strategy for antitumor transition metal complexes;SCIENTIA SINICA Chimica;2024-09-01

4. Multiaction Pt(IV) Complexes: Cytotoxicity in Ovarian Cancer Cell Lines and Mechanistic Studies;Inorganic Chemistry;2024-07-31

5. Discovery of Novel p53-MDM2 Inhibitor (RG7388)-Conjugated Platinum^IV Complexes as Potent Antitumor Agents;Journal of Medicinal Chemistry;2024-05-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3